Meeting NewsVideo

VIDEO: FDA panel gives overwhelming support to Rhopressa approval

NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum here, Tom Mitro, chief operating officer of Aerie Pharmaceuticals, discusses the recent FDA panel on Rhopressa for the treatment of glaucoma.

NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum here, Tom Mitro, chief operating officer of Aerie Pharmaceuticals, discusses the recent FDA panel on Rhopressa for the treatment of glaucoma.

    See more from Medical Technology Innovation Forum